Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Fri, 10.01.2025
Edison Investment Research Limited
London, UK, 10 January 2025
Edison issues report on Baillie Gifford US Growth Trust (USA)
Edison issues report on Baillie Gifford US Growth Trust (LSE: USA)
Baillie Gifford US Growth Trust (USA) invests in exceptional US businesses with the potential to grow substantially faster than the market and deliver above-market returns. Such busin [ … ]
Fri, 10.01.2025
INDUS Holding AG
Company Name:
INDUS Holding AG
ISIN:
DE0006200108
Reason for the research:
Update
Recommendation:
Buy
from:
10.01.2025
Target price:
EUR 34.00
Target price on sight of:
12 months
Last rating change:
Analyst:
Christian Sandherr
Solid FY25e ahead for INDUS due to reasoned capital allocation
Topic: FY24e was clearly overshadowed [ … ]
Fri, 10.01.2025
Nordex SE
Nordex Group breaks the mark of 1 GW of sold turbines in the Hellenic Republic
Hamburg, 10 January 2025. In December 2024, PPC Renewables, a 100 percent subsidiary company of PPC Group, ordered 19 N149/5.X turbines from the Nordex Group in Greece. The turbines with hub heights of 100 metres are intended for three projects totalling 100 MW nominal c [ … ]
Fri, 10.01.2025
Nordex SE
Hamburg, 10 January 2025. In December 2024, the Nordex Group received orders totalling 259 MW from four different customers in Spain. The orders comprise a total of 42 turbines, including 27 N163/5.X turbines, 13 N163/6.X turbines and 2 N149/5.X turbines. The orders also include servicing the turbines - with a term of between ten and 25 years, depe [ … ]
Fri, 10.01.2025
Holcim Group Services Ltd
Holcim takes the next steps towards the planned listing of its North American business and has designated its future Board members. The Board will comprise 10 members and will become effective following the execution of the planned spin-off, expected by the end of the first half 2025, subject to shareholder and customary approvals.
Jan Jenisch is [ … ]
Fri, 10.01.2025
Holcim Group Services Ltd
Holcim’s Board of Directors today announced the proposal of Kim Fausing as Chairman of the Board of Directors of Holcim. Subject to vote at the Annual General Meeting 2025, Kim Fausing will succeed Jan Jenisch, who will not stand for re-election following his appointment as the designated Chairman and CEO of the planned North American company.
Kim [ … ]
Thu, 09.01.2025
DATAGROUP SE
DATAGROUP will not pursue the spin-off of its subsidiary Almato AG
Pliezhausen, January 9, 2025. DATAGROUP SE (“DATAGROUP”, WKN A0JC8S) has completed the review of the spin-off of its 100 % stake in Almato AG (“Almato”) to a separate company as a new holding company. DATAGROUP has come to the conclusion that the planned advantages of a spin-off in [ … ]
Thu, 09.01.2025
Shelly Group SE
Publication of inside information according to Article 17 MARShelly Group announces preliminary consolidated sales revenues FY 2024
Sofia / Munich, 9 January 2025 – Shelly Group SE (Ticker: SLYG / ISIN: BG1100003166) (“Shelly Group” / “the Company”), according to preliminary data has achieved an increase in consolidated sales revenues from the sal [ … ]
Thu, 09.01.2025
Liechtensteinische Landesbank / LLB
Vaduz, 9 January 2025. Liechtensteinische Landesbank AG (LLB) has acquired Zürcher Kantonalbank Österreich AG. On 1 July 2024, LLB had signed the purchase agreement concerning the acquisition of the bank, which has locations in Salzburg and Vienna. The transaction has now been formally concluded as planned.
Effective 9 January 2025, LLB has acquire [ … ]
Thu, 09.01.2025
ABIVAX
Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment
Phase 3 ABTECT Trial evaluating obefazimod for moderately to severely active ulcerative colitis (“UC”) reaches 1,003 of 1,224 participants, representing 82% of target enrollment. Enrollment completion expected in Q2 2025.
Top-line results for the 8-week induction trial anticipated i [ … ]